1. Home
  2. HUDI vs AKTX Comparison

HUDI vs AKTX Comparison

Compare HUDI & AKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HUDI
  • AKTX
  • Stock Information
  • Founded
  • HUDI 1998
  • AKTX N/A
  • Country
  • HUDI China
  • AKTX United States
  • Employees
  • HUDI N/A
  • AKTX N/A
  • Industry
  • HUDI Steel/Iron Ore
  • AKTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • HUDI Industrials
  • AKTX Health Care
  • Exchange
  • HUDI Nasdaq
  • AKTX Nasdaq
  • Market Cap
  • HUDI 17.3M
  • AKTX 17.2M
  • IPO Year
  • HUDI 2021
  • AKTX N/A
  • Fundamental
  • Price
  • HUDI $1.18
  • AKTX $0.47
  • Analyst Decision
  • HUDI
  • AKTX Strong Buy
  • Analyst Count
  • HUDI 0
  • AKTX 2
  • Target Price
  • HUDI N/A
  • AKTX $3.30
  • AVG Volume (30 Days)
  • HUDI 18.5K
  • AKTX 468.9K
  • Earning Date
  • HUDI 08-06-2025
  • AKTX 11-13-2025
  • Dividend Yield
  • HUDI N/A
  • AKTX N/A
  • EPS Growth
  • HUDI N/A
  • AKTX N/A
  • EPS
  • HUDI N/A
  • AKTX N/A
  • Revenue
  • HUDI $66,566,370.00
  • AKTX N/A
  • Revenue This Year
  • HUDI N/A
  • AKTX N/A
  • Revenue Next Year
  • HUDI N/A
  • AKTX N/A
  • P/E Ratio
  • HUDI N/A
  • AKTX N/A
  • Revenue Growth
  • HUDI N/A
  • AKTX N/A
  • 52 Week Low
  • HUDI $1.06
  • AKTX $0.47
  • 52 Week High
  • HUDI $5.46
  • AKTX $2.45
  • Technical
  • Relative Strength Index (RSI)
  • HUDI 37.56
  • AKTX 28.72
  • Support Level
  • HUDI $1.17
  • AKTX $0.60
  • Resistance Level
  • HUDI $1.30
  • AKTX $0.65
  • Average True Range (ATR)
  • HUDI 0.06
  • AKTX 0.07
  • MACD
  • HUDI -0.01
  • AKTX -0.02
  • Stochastic Oscillator
  • HUDI 16.67
  • AKTX 1.98

About HUDI Huadi International Group Co. Ltd.

Huadi International Group Co Ltd is a manufacturer of industrial stainless steel seamless pipes and tubes products. Its products are used in the oil & gas transmission, chemistry engineering, food processing, medical devices, aeronautics and astronautics, boiler, irrigation works construction, automobile and naval architecture, paper mill and mechanical industries. Company generates revenue from Sales of steel piping products. Products are exported to the United States, Mexico, Thailand, Singapore, Argentina, Taiwan, India, the Philippines, UAE and Canada. Geographically, majority revenue is generated from China.

About AKTX Akari Therapeutics plc ADS

Akari Therapeutics PLC is an oncology company developing next-generation antibody-drug conjugates (ADCs) designed around novel, proprietary cancer-killing toxins (payloads). The company believes these novel payloads may have the potential to transform the efficacy and safety outcomes of ADCs as cancer therapies beyond options that are currently available or in development. Its lead product candidate is AKTX-101, a preclinical stage Trop2-targeting ADC that combines PH1 with the Trop2 antibody, which is expressed in the highest number of solid tumor cancer types, including lung, breast, colon and prostate.

Share on Social Networks: